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Abstract
Background: Tuberculosis (TB) is the leading cause of death from an infectious disease in Ethiopia, killing more
than 30 thousand people every year. This study aimed to determine whether the rates of poor TB treatment
outcome varied geographically across Ethiopia at district and zone levels and whether such variability was
associated with socioeconomic, behavioural, health care access, or climatic conditions.
Methods: A geospatial analysis was conducted using national TB data reported to the health management
information system (HMIS), for the period 2015–2017. The prevalence of poor TB treatment outcomes was
calculated by dividing the sum of treatment failure, death and loss to follow-up by the total number of TB patients.
Binomial logistic regression models were computed and a spatial analysis was performed using a Bayesian
framework. Estimates of parameters were generated using Markov chain Monte Carlo (MCMC) simulation.
Geographic clustering was assessed using the Getis-Ord Gi* statistic, and global and local Moran’s I statistics.
Results: A total of 223,244 TB patients were reported from 722 districts in Ethiopia during the study period. Of
these, 63,556 (28.5%) were cured, 139,633 (62.4%) completed treatment, 6716 (3.0%) died, 1459 (0.7%) had
treatment failure, and 12,200 (5.5%) were lost to follow-up. The overall prevalence of a poor TB treatment outcome
was 9.0% (range, 1–58%). Hot-spots and clustering of poor TB treatment outcomes were detected in districts near
the international borders in Afar, Gambelia, and Somali regions and cold spots were detected in Oromia and
Amhara regions. Spatial clustering of poor TB treatment outcomes was positively associated with the proportion of
the population with low wealth index (OR: 1.01; 95%CI: 1.0, 1.01), the proportion of the population with poor
knowledge about TB (OR: 1.02; 95%CI: 1.01, 1.03), and higher annual mean temperature per degree Celsius (OR: 1.
15; 95% CI: 1.08, 1.21).
Conclusions: This study showed significant spatial variation in poor TB treatment outcomes in Ethiopia that was
related to underlying socioeconomic status, knowledge about TB, and climatic conditions. Clinical and public health
interventions should be targeted in hot spot areas to reduce poor TB treatment outcomes and to achieve the
national End-TB Strategy targets.
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Background
Tuberculosis (TB), a bacterial disease caused by Mycobac-
terium tuberculosis, and is the leading cause of death from
an infectious disease worldwide [1]. TB kills more than
one million people every year [1, 2]. Most deaths from TB
could be prevented with early diagnosis and appropriate
treatment. Despite enormous improvement in TB treat-
ment outcomes that have led to the prevention of 53 mil-
lion deaths between 2000 and 2016, there are still major
problems with the treatment of TB [2]. Poor TB treatment
outcomes are disproportionately high in low-income
countries and among low-socio-economic groups within
countries. Identifying patterns of TB treatment outcome
across geographic areas is particularly relevant for TB
control programs and health care providers for planning,
implementing, monitoring, and evaluating control and
prevention efforts to those areas at highest risk.
The Global Burden of Disease (GBD) study [1, 3] and
the World Health Organization (WHO) [2] have produced
national-level estimates of morbidity and mortality from
TB on an annual basis. However, TB treatment outcome
for administrative units of countries such as districts may
differ significantly from the national average. Sub-national
level analyses are important for planning purposes and to
determine where services can further be enhanced.
Spatial epidemiological studies have assessed the incidence
rates of TB in some parts of Ethiopia [4–9]. However, to
date, no spatial epidemiological analyses of TB treatment
outcomes have been reported in Ethiopia. There have been
studies conducted in Iran and Argentina that reported vari-
ability in TB treatment outcomes across districts with low
socio-economic status and difficult access to public transpor-
tation [10, 11]. Understanding the spatial distribution of TB
treatment outcomes is important for measuring the effect of
investments in TB control, and for measuring achievements
of End TB strategies at the local level.
We integrated the national TB surveillance data and the
Ethiopian Demographic and Health Survey (EDHS) data
to quantify geographic variation of TB treatment out-
comes in Ethiopia at the district level and to identify
socio-economic, behavioural, health care access, and cli-
matic factors associated with spatial clustering of poor TB
treatment outcomes.
Methods
Study area
Ethiopia is located in East Africa and shares boundaries
with Eritrea to the North, Djibouti and Somalia to the east,
Sudan and South Sudan to the West, and Kenya to the
South. It is the second-most populous country in Africa.
The last official census report, which was undertaken in
2007, estimated a total population of 74 million [12]. Subse-
quent projections raised the population estimate to 102
million people in 2017 [13]. Approximately 85% of the
population live in rural areas [12]. With a total area of
about 1.1 million square kilometres, Ethiopia is the 10th
and 27th largest country in Africa and in the world, re-
spectively. The country has a variety of geographical fea-
tures; its altitude ranges from 125m below sea level at the
Danakil Depression to 4620m above sea level at mount Ras
Dashen, it contains the source of the Blue Nile and is
bisected by the Great Rift Valley.
Ethiopia is administratively divided into nine regional
states and two city administrative councils (Addis Ababa
and Dire Dawa). Each regional state is further divided
into zones, districts (“woreda”), and neighbourhoods
(“kebeles”). The districts are the decentralized adminis-
trative level and kebeles, within districts, are the lowest
administrative unit in Ethiopia.
TB is the leading infectious cause of death in Ethiopia [14],
killing more than 30 thousand people annually [15, 16].
Ethiopia is one of 30 high TB and MDR-TB burden coun-
tries [17]. The national population based TB prevalence sur-
vey conducted in 2010–2011 revealed that the prevalence of
smear-positive TB among adults and all age group was found
to be 108 and 63 per 100,000 head of population, respect-
ively [18]. According to WHO’s 2014 Global TB report,
Ethiopia has achieved all the three targets of the Millen-
nium Development Goals (MDG) for TB prevention and
control [19]. Mortality and prevalence due to TB has de-
clined by more than 50% and the incidence rate is falling
significantly [19]. However, in the last few years, the TB
treatment success rate has decreased in Ethiopia (from
91% in 2012 to 84% in 2016) [2, 20, 21].
Data sources
Tuberculosis data
District-level TB data (reported from June 2015 to June
2017) were obtained from the Health Management Infor-
mation System (HMIS) managed by the national TB and
leprosy control program (NTLCP). The data include the
number of TB patients enrolled in directly observed ther-
apy, short-course (DOTS) centres in each district with
their treatment outcomes (including the number of pa-
tients with the TB treatment outcomes of cured, treatment
completed, died, treatment failed, and lost to follow-up).
TB treatment outcomes were defined according to NTLCP
guideline definitions [22], which have been adopted from
WHO TB treatment guidelines [23]. In this study, a poor
treatment outcome was defined as the sum of failure, death
and lost to follow up, and treatment success was defined as
the sum of cured and treatment completed. The study in-
cluded pulmonary and extra-pulmonary drug-susceptible TB.
Table 1 shows the definition of TB treatment outcomes.
Independent variables
Data sources for the independent variables are provided
in Table 2. Data on the knowledge and attitudes of the
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population regarding TB were obtained from the EDHS
2011 [24]. Data on health care access and data on behav-
ioural factors such as chat chewing and alcohol drinking
were obtained from the 2016 EDHS [25]. Socio-economic
data such as population density, dependency ratio, average
number of people in the household, unemployed rate, and
literacy rate were obtained from the Ethiopia Atlas of
Population Density, and the wealth index was obtained
from the 2016 EDHS [25]. Climatic and environmental
data such as Enhanced Vegetation Index, rainfall, aridity,
and mean temperature were obtained from the EDHS
Spatial Analysis repository [26].
Knowledge and attitudes regarding TB
Data on the knowledge and attitudes of the population re-
garding TB were obtained from the EDHS 2011 survey (as
the EDHS 2016 survey did not include these data) [24, 25].
These data were collected by semi-structured questions by
means of an interviewer-administered questionnaire. The TB
knowledge of a person was assessed by three questions: 1)
“have you ever heard of an illness called tuberculosis or TB
(yes/no)”; 2) “how can a person get tuberculosis or TB?” and
3) “what symptoms will a person with tuberculosis or TB
have?” A person was categorised as having “good” knowledge
about TB if the person had ever heard about TB, correctly
mentioned the route of transmission (i.e. TB is transmitted
through the air when coughing or sneezing or through
drinking of unboiled milk), and if the person mentioned at
least one TB symptom (i.e. persistent cough for more than 2
weeks, weight loss, poor appetite, night sweats, chest pain or
fever). Those who missed one or more of these three items
were categorized as having ‘poor’ knowledge about TB. The
attitude of a person towards TB was measured by two ques-
tions: 1) can tuberculosis or TB be cured (yes, no, or don’t
know) and 2) if a member of your family got tuberculosis
or TB, would you want it to remain a secret? A “good” atti-
tude was defined by a person believing that TB can be
cured and not wanting a family member’s TB to be kept a
secret. A “poor” attitude was defined by a person believing
that TB cannot be cured or wanting a family member’s TB
diagnosis to be kept a secret.
Health care access
The health care access data were obtained from the
2016 EDHS [25]. As maternal and newborn health are
priorities for the Government of Ethiopia [27], in the
2016 EDHS, the health care access data were collected
only from women. Women (aged 15–49 years) were
asked whether payment for advice or treatment, or the
distance to a health facility, presented major problems in
seeking medical advice or treatment for themselves
when they were sick. We considered that healthcare ac-
cess issues existed if either of these challenges were
identified by the participants. A total of 15,683 women
responded to these questions, of whom 9479 (60%) re-
ported having at least one of the specified problems in
accessing health care.
Behavioural factors
Data on behavioural factors such as chat chewing and al-
cohol drinking were obtained from the 2016 EDHS [25].
Chat chewing was assessed in the 2016 EHDS by asking
the questions: 1) “have you ever chewed chat (yes/no)”;
and 2) “during the last 30 days how many days did you
chew chat?” Similarly, alcohol drinking was assessed by
questions such as: 1) “have you ever taken a drink that
contains alcohol (Tella/Tegi/Areke/Beer/Wine, etc...)
(yes/ no)”; 2) “during the last 30 days, how many days
did you have a drink that contains alcohol?” and 3) “dur-
ing the last 13 months, how often did you take a drink
that contains alcohol (almost every day, at least once a
week, less than once a week, none in the last 13
months)?”. Since the smoking of cigarettes was rare
among the 2016 EDHS participants (less than 1% of
women and 4% of men smoke any type of tobacco), we
did not include cigarette smoking in our study as an in-
dependent variable.
Table 1 definitions of treatment outcomes for tuberculosis patients
Treatment Outcomes Definitions
Cured A pulmonary TB patient with bacteriologically confirmed TB at the beginning of treatment who was smear- or culture-
negative in the last month of treatment and on at least one previous occasion.
Treatment
completed
A TB patient who completed treatment without evidence of failure but with no record to show that sputum smear or culture
results in the last month of treatment and on at least one previous occasion were negative, either because tests were not
done or because results are unavailable.
Treatment failure A TB patient whose sputum smear or culture is positive at month 5 or later during treatment.
Death A TB patient who dies for any reason during the course of treatment.
Lost to follow-up A TB patient whose treatment was interrupted for two consecutive months or more.
Poor treatment
outcome
The sum of failure, death and lost to follow up.
Treatment success The sum of cured and treatment completed.
Alene et al. BMC Infectious Diseases          (2019) 19:474 Page 3 of 11
Socio-economic factors
Socio-economic data such population density, dependency
ratio (defined as number of children (aged under 15 years)
and elderly (aged 65+) divided by the working-age popula-
tion (aged 15–64 years)), average number of people in the
household, unemployed rate, and literacy rate were ob-
tained from the Ethiopia Atlas of Population Density, and
the wealth index was obtained from the 2016 EDHS [25].
The wealth index was calculated in the 2016 EDHS at the
household level. Households were given scores based on the
number and kinds of assets they own, ranging from a televi-
sion to a bicycle or car, in addition to housing characteristics
such as source of drinking water, toilet facilities, and flooring
materials. These scores were derived using principal compo-
nent analysis. National wealth quintiles were compiled by
assigning the household score to each usual (de jure) house-
hold member, ranking each person in the household
population by her or his score, and then dividing the distribu-
tion into five equal categories, each comprising 20% of the
population. We considered those in the poorest and poorer
wealth index quintiles as having a low wealth index and those
in the middle, richer, and richest wealth quintiles as having a
high wealth index. We then calculated the percentage of pa-
tients with a low wealth index in each zone as the total num-
ber of people with a low wealth index divided by the total
number of people who had information on assets in the zone.
Climatic and environmental factors
Climatic and environmental data such as Enhanced Vegeta-
tion Index, rainfall, aridity, and mean temperature were ob-
tained from the EDHS Spatial Analysis repository [26]. The
EDHS program georeferenced these climatic and environ-
mental data with the existing demographic and health survey
data to use for spatial analysis.
Table 2 Summary of independent variables, sources of data and definition of variables
Independent variables Data sources Definition
Socio-economic factors
Low wealth index EDHS 2016 Total number of people with low wealth index (poorer and poorest) divided by the total
number of people participated in the survey.
Population density Ethiopia Atlas of
Population Density
Number of people per square kilometre
Dependency ratio Ethiopia Atlas of
Population Density
Number of children (aged under 15 years) and elderly (aged 65+) dividing by the working-age
population (aged 15–64 years)
Average number of
persons per room
Ethiopia Atlas of
Population Density
Average number of people living in a room
Unemployed
population
Ethiopia Atlas of
Population Density
Percentage of people in the labour force who were unemployed
Adult literacy rate Ethiopia Atlas of
Population Density
Percentage of population aged 15 years and above who had attended higher than secondary
school or who can read and write a short simple statement
Behavioural factors
Chat chewing EDHS 2016 Total number of people chewing chat in the last 1 month prior to the survey divided by the
total number of people participating in the survey
Alcohol drinking EDHS 2016 Total number of people drinking alcohol in the month prior to the survey divided by the total
number of people participating in the survey
Health care access and knowledge and attitude regarding TB
Health care access
problem
EDHS 2016 Difficulty of getting advice or treatment due to lack of money, or distance to a health facility
Good knowledge
toward TB
EDHS 2011 Number of people with good knowledge towards TB divided by the total number of people
participating in the survey.
Good attitude towards
TB
EDHS 2011 Number of people with good attitude towards TB divided by the total number of people
participating in the survey
Climatic and environmental factors
Enhanced vegetation
index
EDHS Spatial Analysis
data
The average enhanced vegetation index which is calculated by measuring the density of green
leaves in the near-infrared and visible bands.
Rainfall EDHS Spatial Analysis
data
Annual mean rainfall (mm)
Aridity EDHS Spatial Analysis
data
The average aridity index calculated by dividing the actual evapotranspiration by the potential
evapotranspiration.
Mean temperature EDHS Spatial Analysis
data
Annual mean environmental air temperature (°C).
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Non-spatial statistical analyses
The prevalence of poor TB treatment outcomes was cal-
culated by dividing the sum of death, treatment failure
and lost to follow up by the total number of TB patients
enrolled in the DOTS program. First, a univariate ana-
lysis was performed by taking the prevalence of poor TB
treatment outcomes as the dependant variable and the
geographical covariates as independent variables. Since
the prevalence of poor TB treatment outcomes at zonal
level was skewed to the right, the log transformed preva-
lence of poor TB treatment outcome was used in the
univariate analysis. Variables with a p-value less than 0.2
in the univariate analysis were selected for the final model
and checked for the presence of multi-collinearity using
variance inflation factors (VIF), excluding variables with a
VIF > 7. When we checked for the presence of
multi-collinearity, a high degree of collinearity was ob-
served among variables from within the same group of in-
dependent variables. Thus, we selected one variable from
each group for the final model to avoid the observed
multi-collinearity. The variables for the final model were
selected first by eliminating implausible variables and then
by using a p-value. The variable that was found to be more
statistically significant was selected for the final spatial
models. Low wealth index, chat chewing, poor knowledge
towards TB, and annual mean temperature were selected
for the final spatial models.
Spatial autocorrelation analysis
Spatial clustering of poor TB treatment outcomes was
explored at a global scale using Moran’s I statistic and at
a local scale using Local indicators of spatial association
(LISA), estimated using the Anselin Local Moran’s I stat-
istic, and the Getis-Ord statistic. The global Moran’s I
statistic was used to assess the presence, strength and
direction of spatial autocorrelation over the whole study
area and to test the assumption of spatial independence
in the implementation of the spatial pattern analysis.
The LISA and the Getis-Ord statistics were used to de-
tect local clustering of poor TB treatment outcomes and
to identify the locations of hot-spots. These analyses
were conducted using tools provided in ArcGIS.
Bayesian spatial analysis
Four different Bayesian models were constructed: un-
structured model (Model I), spatially structured model
without covariates (Model II), spatially structured model
with covariates (Model III), and spatially structured and
unstructured model with covariates (Model IV). Model
IV includes all the components in the preceding models.
These models were constructed using WinBUGS version
1.4.3 software (Medical Research Council Biostatistics
Unit, Cambridge, United Kingdom). The details of the
models are presented in the Additional file 1: Table S1.
We assumed that the observed prevalence of poor TB
treatment outcome (r) at zone (i) had a binomial distri-
bution with a total number of TB patients enrolled for
treatment at the zone (ni) and the predicted prevalence
of poor treatment outcomes at the zone (pi): ri ~ Bino-
mial (ni, pi). Model IV for pi was specified as follows:
logit pið Þ ¼ αþ
X
N
βn  Xn;i þ Ui þ Vi
Where pi is the probability of a poor treatment out-
come in zone i; α is the intercept;
X
N
βn  Xn;i is the
matrix of independent zone-specific variables (X, i.e.
proportion of the population with a low wealth index,
chat chewing and poor knowledge towards TB, and
mean annual temperature) measured at each zone i,
multiplied by their coefficients (β); Ui are unstructured
random effects; Vi are the spatially structured random
effects, modelled using conditional autoregressive (CAR)
approach. The CAR component was defined using an
adjacency matrix to determine the spatial relationships
between zones. The adjacency matrix for each zone was
generated using ArcGIS based on the queen definition,
whereby two areas are considered neighbours if they
share a common boundary or vertex. A weight of 1 was
given if two zones were neighbours and a weight of 0
was given if two zones were not neighbours.
The posterior parameters were estimated using a Bayesian
Markov Chain Monte Carlo (MCMC) simulation. Non-
informative priors were specified for the intercept α (a
non-informative, improper prior with bounds - ∞ and +∞)
and the coefficients (normal prior with mean = 0 and preci-
sion 1× 10− 6). The priors for the precision of the unstruc-
tured and spatially structured random effects were assigned
non-informative gamma distributions with shape and scale
parameters set at 0.001. The deviance information criterion
(DIC) statistic was calculated to select the best-fitting model
(models with a lower DIC statistic are considered to show a
better compromise between model fit and parsimony). The
model was run for 1,000,000 iterations and convergence was
successfully achieved after 900,000 iterations. Convergence
of the models was determined by visual inspection of poster-
ior kernel density and history plots.
Results
Tuberculosis treatment outcomes in Ethiopia
A total of 223,244 patients in 722 districts were reported
to the national NTLCP (through the HMIS) during the
period June 2015 and June 2017. Of these, 63,556 (28.5%)
were cured, 139,633 (62.4%) completed treatment, 6716
(3.0%) died, 1459 (0.7%) had treatment failure, and 12,200
(5.5%) were lost to follow-up. The overall prevalence of
poor TB treatment outcomes was 20,375 (9.0%). Figure 1
presents the spatial distribution of poor TB treatment
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outcomes in Ethiopia at the zone level. The prevalence of
poor TB treatment outcomes varied from 1% in East Harerge
Zone, Oromia region to 58% in Stang Special Zone, Gambelia
region (Fig. 1). The districts with the highest prevalence of
poor TB treatment outcomes were located in West and East
Ethiopia in the Afar, Gambelia, and Somali regions, whereas
districts with a lower prevalence of poor TB treatment out-
comes were mainly located in the central part of Ethiopia in-
cluding in the Oromia and Amhara regions.
Spatial clustering of poor TB treatment outcomes in
Ethiopia
Spatial clustering of poor TB treatment outcomes was ob-
served in Ethiopia both at district (Global Moran’s I =
0.06, p-value = < 0.001) and zone levels (Global Moran’s I
= 0.10, P-value = 0.04). Figure 2 shows that high-high clus-
ters of poor TB treatment outcomes were observed in dis-
tricts located in Gambelia, Afar and Somalia regions.
Similarly, Fig. 3 shows that hot spots of poor TB treatment
outcomes were detected in districts located in Gambelia,
Afar and Somalia regions. The districts where hot spots
and high clustering of poor TB treatment outcomes were
observed are located in the border regions of Ethiopia,
and are characterized by high annual mean temperature,
and low levels of health care access. Cold spots of poor
TB treatment outcomes were detected in central Ethiopia,
mainly in Oromia and Amhara regions (Fig. 3).
Factors associated with poor TB treatment outcomes
Table 3 presents the univariate analysis showing the as-
sociation between poor TB treatment outcomes and
ecological-level socio-economic, behavioural, health care
access and climatic variables. Table 4 shows the Bayesian
spatial and non-spatial models for poor TB treatment
outcomes with and without covariates. The model that
contained covariates with an unstructured random effect
was the best-fitting, most parsimonious model according
to the value of the DIC statistic. The proportion of the
population with low wealth index ((Odds Ratio (OR):
1.01; 95%CI: 1.0, 1.01), the proportion of the population
with poor knowledge about TB (OR: 1.02; 95%CI: 1.01,
1.03), and higher annual mean temperature per degree
Fig. 1 Choropleth map showing the geographical distribution of poor tuberculosis treatment outcome by zone in Ethiopia, June 2015 to
June 2017
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Celsius (OR: 1.15; 95% CI: 1.08, 1.21) were positively as-
sociated with a poor TB treatment outcome. When the
independent variables were incorporated into the model,
spatial clustering was not apparent in the residuals (Glo-
bal Moran’s I = − 0.01; p-value = 0.23), indicating that the
covariates could explain the spatial clustering in poor
TB treatment outcomes.
Discussion
This nation-wide study identified substantial variability in the
prevalence of poor TB treatment outcomes across districts
and zones of Ethiopia. These inequalities were associated
with underlying differences in multiple area-level socioeco-
nomic and climatic factors and knowledge of TB. For ex-
ample, low wealth index, high annual mean temperature,
and poor knowledge about TB were associated with poor TB
treatment outcomes. Moreover, significant geographic clus-
tering was apparent, with poor TB treatment outcome hot
spots in the border regions and cold spots in the central
regions of Ethiopia. Notably, the selection of the non-spatial
Bayesian model as the best-fitting model indicates that the
spatial clustering of poor treatment outcomes observed in
the exploratory analysis was largely explained by the model
covariates. The associations between poor TB treatment out-
come and markers of socioeconomic status, climatic factors,
and health care access have important clinical and public
health implications, suggesting high-risk areas that could be
targets for enhanced activities for prevention and control of
TB.
Geographic variability exists for multiple health conditions
in Ethiopia, particularly infectious diseases [8, 28–30]. We
previously demonstrated that rates of paediatric TB and
multidrug-resistant TB vary across districts in Ethiopia [8, 9].
However, to our knowledge, no previous published study has
assessed spatial variability in TB treatment outcomes in
Ethiopia. In Iran, Kolifarhood et al. reported variability in
successful TB treatment outcomes across two districts of
Urmia [10]. A study in Argentina found spatial clustering of
Fig. 2 Spatial clustering of poor tuberculosis treatment outcomes at district-level in Ethiopia, 2015 to 2017, based on Local indicators of spatial
association using Anselin Local Moran’s I statistic
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loss to follow up across districts with low socio-economic
status and difficult access to public transportation [11]. We
found that the overall prevalence of poor TB treatment
outcomes was 9%, which is consistent with the global TB
report [2, 21]. However, when we assessed poor TB treat-
ment outcomes at the district and zone levels, these out-
comes ranged from 1 to 58%. This finding highlights the
high degree of variability in poor TB treatment outcomes
that exists within just one country, masked by an overall
national TB treatment success rate (84%) [16].
Hot spots of poor TB treatment outcomes were detected
in districts located in Afar, Somalia and Gambelia regions.
These regions are located in the border areas of Ethiopia and
are characterised by high air temperatures. For example, the
maximum temperature reaches 40 °C in the Somalia region
and 48 °C in the Afar region. Our findings also showed that
higher annual mean temperature is associated with poor TB
treatment outcomes. Temperature may impact on the
efficacy of the drugs that are used to treat TB, and therefore,
transmission. However, this relationship could be also con-
founded by other factors. Clearly, future studies are needed
to better understand why increased environmental air tem-
peratures are associated with poor TB treatment outcomes
and what interventions are best suited toward preventing
poor TB treatment outcome in hot environments.
The majority of the people who live in Afar and Somalia
regions, where hot spots of poor TB treatment outcomes
were observed, are pastoralists who are dependent on live-
stock for their income. These group of people are nomads
who move from place to place to get feed for their live-
stock [27]. Since many of the settlements and villages in
these regions are of a temporary nature, the development
of basic infrastructure (i.e. schools, health care facilities,
and water supply) is challenging [27]. As a result, in these
regions, infrastructure and health care services are under-
developed [27]. Designing TB treatment programmes for
Fig. 3 Spatial clustering of poor tuberculosis treatment outcomes at district-level in Ethiopia, 2015 to 2017, based on the Getis-Ord Gi* statistic
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nomadic communities, and for people living in border
areas that take migratory practices into account, could be
important to increase access to TB care and achieve suc-
cessful TB treatment outcomes. A study conducted in
Nigeria showed that active case finding for TB among no-
madic populations increased case notification and suc-
cessful treatment outcomes [31]. This approach is
particularly important for Ethiopia to achieve the END TB
targets of ending TB related deaths, transmission and
catastrophic costs by 2035 [32].
Variability in the prevalence of poor TB treatment out-
comes was significantly associated with underlying vari-
ability in area-level socioeconomic status. This finding is
consistent with previous studies assessing such relation-
ships with TB treatment outcomes in Ethiopia [33, 34]
Such findings are not surprising given the extensive
Table 3 Univariate model for poor tuberculosis treatment outcomes at the zone level in Ethiopia, 2015–2017
Independent variables Coefficient (95% CI) P-value
Socio-economic factors
Low wealth index 0.01 (0.005, 0.016) < 0.001
Population density 0.00002 (−0.00004, 0.00009) 0.429
Dependency ratio −1.01 (−1.85, − 0.192) 0.016
Average number of persons per room 0.23 (0.11, 0.350) 0.001
Unemployed population 0.0535 (0.025, 0.082) < 0.001
Adult literacy rate −0.0088 (− 0.013, − 0.0002) 0.045
Behavioural factors
Chat chewing −0.011 (− 0.02, − 0.003) 0.011
Alcohol drinking − 0.0039 (− 0.009, 0.001) 0.115
Health care access
Health care access problem −0.0001 (− 0.01, 0.008) 0.995
Poor knowledge towards TB 0.003 (0.0015, 0.009) 0.046
Poor attitude towards TB 0.002 (−0.007, 0.012) 0.653
Climatic factors
Enhanced vegetation index −0.0001 (− 0.0003, −6.59e-06) 0.041
Rainfall −0.0001 (− 0.0003, −4.93e-06) 0.044
Aridity − 0.0001 (− 0.0001, − 0.00003) 0.001
Mean temperature 0.133 (0.09, 0.168) < 0.001
Table 4 Bayesian logistic regression model for the association of socio-economic, behavioural, climatic condition and spatially
structured and unstructured random effect at the zone level with poor tuberculosis treatment outcomes in Ethiopia, 2015 to 2017
Variables Unstructured model Structured model Structured & unstructured model Model without covariates
OR, Posterior
Mean (95%
CrI
OR, Posterior
Mean (95%
CrI
OR, Posterior
Mean (95%
CrI
Chat chewing 0.99 (0.98, 1.00) 0.99 (0.98, 1.00) 0.99 (0.98, 1.00) –
Low wealth index 1.01 (1.00, 1.01) 1.01 (1.00, 1.01) 1.01 (1.00, 1.01) –
Knowledge towards TB 1.02 (1.01, 1.03) 1.013 (1.00, 1.03) 1.02 (1.01, 1.03) –
Mean temperature 1.15 (1.08, 1.21) 1.12 (1.045, 1.18) 1.14 (1.08, 1.20) –
Constant (alpha) −5.57 (−6.64, −4.39) −5.04 (− 6.17, −3.74) − 5.48 (− 6.51, − 4.37) −2.11 (−2.14, −2.07)
Heterogeneity
Unstructured variance 0.63 (0.53, 0.74) – 0.24 (0.028, 0.83)
Structured variance – 1.264 (1.07, 1.50) 0.59 (0.42, 0.73) 1.57 (1.34, 1.84)
DIC 746.0 764.5 752.0 760.8
CrI credible interval, DIC deviance information criterion, OR odds ratio
The boldface indicate statistically signficant variables
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literature on the influence of individual-level socioeco-
nomic deprivation on TB prevalence [35–37].
The observed associations between area-level socioeco-
nomic status and area-level prevalence of poor TB treatment
outcome highlight the potential benefit of identifying hotspot
targets for clinical and public health interventions. For ex-
ample, provision of health education for targeted communi-
ties is important to increase the TB-related knowledge, a
consideration supported by our findings [38]. Up to date in-
formation on district or zone-level TB “hot spots” could be
used to inform healthcare planning, including prioritisation
of resources that might strengthen the DOTS program.
This study has a number of limitations. First, the
prevalence of poor TB treatment outcomes for a district
or zone may vary with time. We used the most recent 2
years of data reported to the Ministry of Health after the full
implementation of the HMIS. Second, although the data
covered all zones and regions of Ethiopia, there were no TB
data available for 32 districts. Third, the ecological study de-
sign did not allow us to determine causation or directionality
of association between poor TB treatment outcomes and
zone and district–level characteristics. Fourth, we depended
on data reported to the health care facilities. However, all pa-
tients withTB may not visit the health care facilities and thus
we were unable to directly measure the prevalence of poor
TB treatment outcomes in the community, including
longer-term follow-up of patients who “completed treat-
ment” to determine long-term outcomes. Fifth, since the
study was based on district-level aggregated data, some im-
portant demographic and clinical variables such as age, sex,
weight, human immunodeficiency virus (HIV) status, initial
bacterial load, and drug susceptibility patterns were not avail-
able in the reports and therefore were not included in our
study. Demographic variables such sex and age may have a
significant effect on the geographical distribution of poor TB
treatment outcomes; however, such data were not available
and thus not included in the study. Sixth, the assessment of
access to health care was based on data obtained only from
women, which might have introduced bias.
Conclusions
The prevalence of poor TB treatment outcomes varied
substantially across districts and zones in Ethiopia. This
variability was significantly associated with underlying dif-
ferences in zone–level socioeconomic status, knowledge
about TB, and mean annual temperature. Hot spots of
poor TB treatment outcomes were observed in districts
located in the border region of Ethiopia (i.e. Afar, Somalia,
and Gambelia regions), where pastoralist communities
live. Cold spots were present in districts located in central
Ethiopia (i.e. in Amhara and Oromia region). Clinical and
public health interventions should be targeted to hot spot
areas to improve TB treatment outcomes and to achieve
the national End-TB Strategy targets.
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